Philadelphia transplant programs risk losing U.S. funds
The failure to attract enough patients amid heavy competition among Philadelphia-area organ-transplant programs has closed one and put two others at risk. The liver program at Hahnemann University Hospital and the heart-transplant program at Temple University Hospital are in jeopardy of losing Medicare certification and government payments for the operations. Hahnemann and Temple were among a first wave of transplant hospitals nationwide to face intensified scrutiny of surgical volumes and outcomes from federal regulators. Both have until early May to get their numbers back up.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC